Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence
EVIDENCE FOR PREVENTION OF BORDERLINE LEPROSY REACTIONS BY DAPSONE
Preoperative mFOLFIRINOX versus PAXG for stage I–III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial
Borderline
HPV test helps resolve borderline cervical-smear tests
Reforming the borderline personality diagnosis
Risk factors for type-1 reactions in borderline leprosy patients
Spatial proteo-transcriptomic profiling reveals the molecular landscape of borderline ovarian tumors and their invasive progression
